Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells.

MLA

Duan, Lei, et al. “Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-Induced Cytotoxicity in Estrogen Receptor-Positive Breast Cancer Cells.” The Journal of Biological Chemistry, vol. 286, no. 4, Jan. 2011, pp. 2864–76. EBSCOhost, https://doi.org/10.1074/jbc.M110.143271.

APA

Duan, L., Motchoulski, N., Danzer, B., Davidovich, I., Shariat-Madar, Z., & Levenson, V. V. (2011). Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells. The Journal of Biological Chemistry, 286(4), 2864–2876. https://doi.org/10.1074/jbc.M110.143271

Chicago

Duan, Lei, Natalia Motchoulski, Brian Danzer, Irina Davidovich, Zia Shariat-Madar, and Victor V Levenson. 2011. “Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-Induced Cytotoxicity in Estrogen Receptor-Positive Breast Cancer Cells.” The Journal of Biological Chemistry 286 (4): 2864–76. doi:10.1074/jbc.M110.143271.